Background: Breast cancer is the most prevalent malignancy among Iranian women. Five and ten year survival is one of the indicators used for evaluation of the quality of care after surgery. In this study, we used several survival models to determine risk factors, survival times and life expectancies of different types of surgery. Methods: This study was performed on 310 patients who underwent surgery during a ten years period. Logistic regression and Cox regression models were used to analyze the factors leading to death. The Kaplan-Meier method (non-parametric) was used to estimate the survival rate. The log-rank test was used to compare survival in different groups. To compare life expectancy of different types of surgery, we used the act...
OBJECTIVES A survival analysis of breast cancer patients in southern Iran according to age has yet t...
Objective: In this study, we aimed to compare the results of the survival analysis of the patients w...
Breast cancer is one of the malignant tumors that begins in the breast cells that develop and attack...
Background: Breast cancer is the most prevalent malignancy among Iranian women. Five and ten year su...
Abstract Background: Breast cancer is the most prevalent malignancy among Iranian women. Five and te...
Background: Breast cancer is the most prevalent malignancy among Iranian women. Five and ten year su...
Context: Breast cancer is the most common cancer and the second common cause of cancer-induced morta...
Factors affecting the time of survival after breast cancer (BC) diagnosis remain unknown. However, s...
Background and Objectives: Breast cancer is the leading cause of death from cancer among women. In d...
BACKGROUND AND OBJECTIVE: Breast cancer is one of the most common cancers in women. The statistical ...
BACKGROUND AND OBJECTIVE: Breast cancer is one of the most common cancers in women. The statistical ...
Background: Breast cancer is the most common cancer and the second most common cause of cancer-induc...
Introduction: Breast cancer is the most common malignancy in women which causes 19 of annual deaths ...
Introduction: According to recent epidemiologic studies, the prevalence of breast cancer is growing ...
Background: Breast cancer is a common disease among women around the world. In Iran, it is the most ...
OBJECTIVES A survival analysis of breast cancer patients in southern Iran according to age has yet t...
Objective: In this study, we aimed to compare the results of the survival analysis of the patients w...
Breast cancer is one of the malignant tumors that begins in the breast cells that develop and attack...
Background: Breast cancer is the most prevalent malignancy among Iranian women. Five and ten year su...
Abstract Background: Breast cancer is the most prevalent malignancy among Iranian women. Five and te...
Background: Breast cancer is the most prevalent malignancy among Iranian women. Five and ten year su...
Context: Breast cancer is the most common cancer and the second common cause of cancer-induced morta...
Factors affecting the time of survival after breast cancer (BC) diagnosis remain unknown. However, s...
Background and Objectives: Breast cancer is the leading cause of death from cancer among women. In d...
BACKGROUND AND OBJECTIVE: Breast cancer is one of the most common cancers in women. The statistical ...
BACKGROUND AND OBJECTIVE: Breast cancer is one of the most common cancers in women. The statistical ...
Background: Breast cancer is the most common cancer and the second most common cause of cancer-induc...
Introduction: Breast cancer is the most common malignancy in women which causes 19 of annual deaths ...
Introduction: According to recent epidemiologic studies, the prevalence of breast cancer is growing ...
Background: Breast cancer is a common disease among women around the world. In Iran, it is the most ...
OBJECTIVES A survival analysis of breast cancer patients in southern Iran according to age has yet t...
Objective: In this study, we aimed to compare the results of the survival analysis of the patients w...
Breast cancer is one of the malignant tumors that begins in the breast cells that develop and attack...